Symbols

INMD

InMode·NASDAQ

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 1

Ample Liquidity

High Gross Profit Margin

Revenue Beats Expectation

Undervalued

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About INMD

Inmode Ltd.

A leading global provider of radio frequency devices that used in minimally & non-invasive cosmetic procedure and women's health

Industry

Healthcare Equipment and Supplies

Established Date

01/02/2008

Listing Date

08/08/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

660

Fiscal Year Ends

12-31

Website

www.inmodemd.com

Security Type

Common stock

Office address

Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, 2069206, Israel

Business

Introduction

InMode Ltd., incorporated in the State of Israel as a limited liability company on January 2, 2008, operates under its laws. The company is committed to the design, development, production and sales of innovative minimally invasive beauty and medical products based on its proprietary RF-assisted lipolysis and deep subcutaneous dot matrix RF technology. These techniques can be used to reshape subcutaneous adipose tissue for a variety of surgeries, including liposuction combined with skin tightening, body and facial contouring, and exfoliative skin regeneration therapy, as well as for certain women's health issues and related surgeries. In addition to minimally invasive technology, the company also designs, develops, produces and sells non-invasive medical beauty products covering a variety of surgeries, including permanent hair removal, facial skin regeneration, wrinkle removal, cellulite treatment, improvement of skin texture and skin feel, and treatment of superficial benign vascular and pigmented lesions. The company also designs, develops, manufactures and sells hands-free medical beauty products for various surgeries such as skin tightening, fat reduction and muscle stimulation.

Company Financials

EPS

INMD has released its 2025 Q4 earnings. EPS was reported at 0.46, versus the expected 0.42, beating expectations. The chart below visualizes how INMD has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

INMD has released its 2025 Q4 earnings report, with revenue of 103.85M, reflecting a YoY change of 6.13%, and net profit of 27.02M, showing a YoY change of -67.35%. The Sankey diagram below clearly presents INMD's revenue sources and cost distribution.